Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Forestieri G, Terzi di Bergamo L, Deodato M, Frustaci AM, Moia R, Deambrogi C, Rasi S, Autore F, Merli M, Mattarucchi R, Fahrni G, Scarfo' L, Gussetti D, Bulian P, Zanatta A, Spina V, Bruscaggin A, Pini K, Piffaretti D, Pirosa MC, Salehi M, Marques de Almeida J, Passweg J, Cavalli F, Zucca E, Gerber B, Stussi G, Gattei V, Ghia P, Gregor M, Passamonti F, Laurenti L, Gaidano G, Tedeschi A, Rossi D, Condoluci A.
Forestieri G, et al. Among authors: bulian p.
Hematol Oncol. 2022 Dec;40(5):1100-1104. doi: 10.1002/hon.3032. Epub 2022 Jun 1.
Hematol Oncol. 2022.
PMID: 35613703
No abstract available.